Who
Julie Rubinstein
President and COO
Company insider
Files Form 4 as: President and COO, Adaptive Biotechnologies.
In numbers
- Trades disclosed
- 626
- Buys
- 0
- Sells
- 115
- Bought
- $0
- Sold
- $99.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Dec 2019
- Last trade
- 16 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Oct 2026filed 16 Oct 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,881 at $0.00 | filing |
| 16 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $144K11,881 at $12.14 | filing |
| 16 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $280K11,581 at $24.21 | filing |
| 16 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $7,635300 at $25.45 | filing |
| 15 Oct 2026filed 16 Oct 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,881 at $0.00 | filing |
| 15 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $144K11,881 at $12.14 | filing |
| 15 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $304K11,881 at $25.61 | filing |
| 14 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $144K11,881 at $12.14 | filing |
| 14 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $173K6,781 at $25.57 | filing |
| 14 Oct 2026filed 16 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $132K5,100 at $25.82 | filing |
| 14 Oct 2026filed 16 Oct 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,881 at $0.00 | filing |
| 13 Oct 2026filed 13 Oct 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,881 at $0.00 | filing |
| 13 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $144K11,881 at $12.14 | filing |
| 13 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $303K11,881 at $25.50 | filing |
| 12 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $144K11,881 at $12.14 | filing |
| 12 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $233K9,181 at $25.35 | filing |
| 12 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $70K2,700 at $26.07 | filing |
| 12 Oct 2026filed 13 Oct 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,881 at $0.00 | filing |
| 9 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $144K11,881 at $12.14 | filing |
| 9 Oct 2026filed 13 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $314K11,881 at $26.41 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 11,881 Shares of Stocktickerreport.com · 14 Oct 2026Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Sharestickerreport.com · 6 Oct 2026Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 6,444 Shares of StockADPT · themarketsdaily.com · 9 Oct 2026Analyzing Adaptive Biotechnologies (NASDAQ:ADPT) & MindWalk (NASDAQ:HYFT)ADPT · dailypolitical.com · 8 Oct 2026Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $346,806.39 in StockADPT · tickerreport.com · 8 Oct 2026
2 headlines in the last 90 days name Julie Rubinstein; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.